Citrullin treatment for ornithin transcarbamylase deficiency

Citrullin treatment for ornithin transcarbamylase deficiency - Citrullin treatment for ornithin transcarbamylase deficiency

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013397

Enrollment

Registered

2020-04-01

Start date

2012-07-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ornithin transcarbamylase deficiency

Interventions

Citrullin administration

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: OTC deficiency

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Decrease of blood anmonia levels	—

Countries

Japan

Contacts

Public ContactYasuhiro Takeshima

Kobe University Pediatrics

takesima@med.kobe-u.ac.jp078-382-5111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026